RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations

  • Richard L. Wasserman, Benjamin N. Greener, James Mond
  • Expert Review of Clinical Immunology, October 2017, Taylor & Francis
  • DOI: 10.1080/1744666x.2017.1389647

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/1744666x.2017.1389647